PharmaDB
Alternatives · Cortellis vs PharmaDB · sourcing-first comparison v.05.2026 · refreshed weekly
Alternatives · for the sourcing question, specifically

Researching Cortellis? Here's where sourcing intelligence lands differently.

Cortellis is the industry standard for the regulatory clock and the pipeline view. It is trusted by 100% of the top 20 pharma companies for compliance and creation work.1 The sourcing question underneath, who actually ships this API, on what lane, at what concentration, with what compliance trail, is a different surface. PharmaDB is the answer there. One independent guide describes the difference plainly: "Cortellis answers 'What drugs are in development?' PharmaDB answers 'Who's manufacturing and shipping products?'"2

Sourcing-first graphPer-run rate cardCustoms ⋈ regulatory ⋈ plants
Scope · three honest axes

Where each tool actually goes deep.

Pricing model
What does a year of use cost, and can you see the number before talking to sales?
Cortellis

Enterprise quote, no published rate card. Capterra lists the starting price as "Contact vendor for pricing" with no free trial.3 Independent analysis of Clarivate contracts reports them as "six figures annually, with multi-year commitments", with BD teams paying "$100,000+ for what is fundamentally an expensive research interface."4 Coverage and modules available depend on which entitlements were purchased.5

PharmaDB

Published banded rate card. Lookup fees banded by how many graph queries the agent fires inside a run: $0.20 under 10 lookups, $0.50 for 10 to 50, capped at $1.00 per run for 50+. AI usage at 20% over Anthropic's published rates, line by line in your chat. $100 minimum top-up, credits valid 12 months. Pro tier $5,000 a year covers both lookups and AI, plus watchlist, export, and a forthcoming API. Numbers on the page before the conversation.

Data depth
What does the underlying graph actually contain?
Cortellis

Cortellis Generics & Products Intelligence describes itself as "a single source of global drug, market, API, and patent data", listing 63k+ molecules, 72k+ manufacturers, 1.4m+ worldwide patents, and biopharma pricing across 90+ markets.6 Cortellis Regulatory Intelligence covers "310,000+ regulatory documents" across 80+ jurisdictions.7 Cortellis CMC Intelligence covers "global chemistry, manufacturing and controls (CMC) requirements".8 Across these product pages, trade flows, lane-level concentration, and FDA 483 or import-alert trajectories are not named as data domains.6,7,8

PharmaDB

Trade flows joined to FDA Type II DMF and EDQM CEP registers, plant inspections, warning letters, and import alerts. Lane-level HHI, top-3 exporter share, active-exporter counts, and median USD per kilogram percentiles are first-class objects in the graph.

Primary user
Who is the seat for, day to day?
Cortellis

Cortellis Competitive Intelligence is built for "portfolio strategy, licensing and business development, competitive intelligence, and R&D investment planning", tracking 100,000+ pipeline drugs across 3,000+ diseases.9 Cortellis Regulatory Intelligence is built for regulatory affairs; a Global Head of Regulatory Intelligence at a top 50 pharma describes using it "every day to stay compliant."10 The workflow is multi-year planning around a pipeline asset.

PharmaDB

API procurement, BD sourcing, supply continuity, finance pre-RFQ. The workflow is "qualify this lane, this quarter, before we issue the order." Designed for the same buyer one Cytel customer described being stuck with before consolidating: "We had a variety of tools, and that was the pain, the variety. We had to go to multiple places to get streamlined data."4

Live example · trastuzumab biosimilar, India → US, 2024

What the sourcing question looks like, answered.

Cortellis tracks the regulatory timeline of trastuzumab biosimilars: marketing applications, approvals, clinical holds, labelling changes, and CMC filings across 80+ jurisdictions.7 Below is the sourcing-side picture for the same molecule, surfaced from PharmaDB's warehouse. Same molecule, orthogonal depth.

Lane HHI
1.00
structural single-source
Top-3 share
100%
no #4 exporter
Active exporters
6
tight cohort
Lane value
$12.2M
small but absolute

The India to US trastuzumab biosimilar lane currently has six declared exporters, the top three account for 100% of inbound value, and any disruption to the leading exporter takes the lane offline. The Cortellis page and the PharmaDB page stack rather than substitute. One tells you when the regulatory window opens; the other tells you whether the supply behind the window can actually carry an order.

lane_competitiveness · 2024molecule_country_flow · 34 shipmentsfda_inspections · last 3 cycles
Decision framework · honest assessment

When to use each.

Cortellis is the right tool when
  • The question is the regulatory clock: marketing applications, approvals, clinical holds, labelling changes across 80+ jurisdictions.7
  • The user is regulatory affairs and needs to "confidently navigate the global pharma regulatory landscape, maintain compliance, and make strategic decisions with AI-assisted regulatory intelligence."7
  • The question is IP exposure: Paragraph IV challenges, patent families, Supplementary Protection Certificates (26k+ tracked in Cortellis Generics).6
  • The workflow is portfolio strategy across "100,000+ pipeline drugs" and 3,000+ diseases through the full development lifecycle.9
  • The team already runs Cortellis CMC for pre and post-approval filing requirements in 130+ countries.8
PharmaDB is the right tool when
  • The question is "who exports this API, on this lane, at what concentration, this quarter."
  • The user is API procurement, BD sourcing, supply continuity, or pre-RFQ finance.
  • The workflow needs trade flows joined to FDA Type II DMF and EDQM CEP registers in one query, with anonymisation at the query layer.
  • The risk lens is plant-level: 483 trajectories, warning letters, import alerts overlaid on the exporter cohort that actually moves volume.
  • The pricing test is small: a $100 top-up against one live lane question, no annual commitment, no per-seat fee.
Ask the AI agent · the sourcing question Cortellis isn't built for

One question, one citation-anchored answer.

"Compute the lane HHI and top-3 exporter share for trastuzumab biosimilar, India to US, last 24 months. Then surface the dual-source posture if HHI is over 0.40."
Run this in the AI agent One run · typically 1–3 lookups · $0.20 band on PAYG plus AI at 20% over Anthropic's rates

Questions, answered.

Does PharmaDB replace Cortellis?

No. They cover different surfaces. Cortellis is the pipeline, IP, and regulatory record, trusted by 100% of the top 20 pharma companies for that work.1 PharmaDB is the sourcing graph underneath: customs, exporter cohorts, plant inspections, dossier registers. Teams that need both run both.

What does PharmaDB cover that Cortellis doesn't?

Across the Cortellis Generics, Regulatory, and CMC product pages, the named data domains are drug, market, API, patent, sales, manufacturer, and CMC filing data.6,7,8 Trade flows flows, exporter shares per lane, Lane HHI and top-3 share, plant inspection trajectories, warning letter and import-alert overlays, and median USD per kilogram percentiles are not named on those pages. PharmaDB ships those as first-class objects.

How does pricing compare?

Cortellis is sold by enterprise quote, with annual contracts and seat counts; Capterra lists the starting price as "Contact vendor for pricing", and independent analysis reports contracts at "six figures annually, with multi-year commitments."3,4 PharmaDB is consumption-based: $0.20 per run starting band, $1.00 maximum per run on lookups, plus AI usage at 20% over Anthropic's published rates. $100 minimum top-up. Pro is $5,000 a year covering both lookups and AI, plus watchlist, export, and API.

I'm a regulatory affairs lead. Which one?

Probably Cortellis. A Global Head of Regulatory Intelligence at a top 50 pharma describes Cortellis Regulatory Intelligence as "used every day to stay compliant."10 PharmaDB adds value when a procurement decision is downstream of the regulatory milestone, not when the regulatory milestone is the question itself.

What about the user-experience reports of module fragmentation?

One independent guide observes that "the user experience can be fragmented across its various modules (Regulatory, CI, Clinical, Deals), although efforts are underway to unify them on the Cortellis Cloud", and that "the breadth of data can sometimes result in 'overlapping content' confusion between legacy modules."5 PharmaDB ships one chat surface against one graph; lookups and AI usage line by line per run.

What's the switching cost from Cortellis?

There isn't one, because there isn't a switch. PharmaDB sits alongside; the cost is the per-run rate on the questions it newly answers. With Clarivate having announced in February 2026 that it is "exploring a sale of its Life Sciences & Healthcare business",11 a number of teams are pairing their existing Cortellis seat with a $100 PAYG top-up on a single live sourcing question before deciding on Pro.

Sources.

  1. "Cortellis Regulatory Intelligence" product page, Clarivate. Claim that the platform is trusted by 100% of the top 20 pharma companies. https://clarivate.com/life-sciences-healthcare/research-development/regulatory-compliance-intelligence/regulatory-intelligence-solutions/
  2. "Top 10 Cortellis Alternatives & Competitors in 2026", G2. Surfaces the framing "Cortellis answers What drugs are in development? PharmaDB answers Who is manufacturing and shipping products?" https://www.g2.com/products/cortellis/competitors/alternatives
  3. "Cortellis Software Pricing, Alternatives & More 2026", Capterra. Starting price listed as "Contact vendor for pricing", no free trial. https://www.capterra.com/p/234938/Cortellis/
  4. "Top 5 Clarivate Alternatives for Life Sciences Teams (2026)", Salesmotion. Analysis citing six-figure annual contracts, multi-year commitments, and the Cytel customer quote on tool fragmentation. https://salesmotion.io/clarivate-alternatives
  5. "Cortellis Explained: A Guide to the Life Sciences Platform", IntuitionLabs. Independent guide noting module fragmentation, overlapping content confusion, and that coverage depends on entitlements purchased. https://intuitionlabs.ai/articles/clarivate-cortellis-guide
  6. "Cortellis Generics & Products Intelligence", Clarivate. Verbatim tagline and named data domains: 63k+ molecules, 72k+ manufacturers, 1.4m+ patents, 26k+ SPCs, biopharma pricing across 90+ markets. https://clarivate.com/life-sciences-healthcare/manufacturing-supply-chain-intelligence/product-intelligence-analytics/
  7. "Cortellis Regulatory Intelligence", Clarivate. Verbatim tagline and the 310,000+ regulatory documents claim across 80+ jurisdictions. https://clarivate.com/life-sciences-healthcare/research-development/regulatory-compliance-intelligence/
  8. "Cortellis CMC Regulatory Intelligence", Clarivate. Verbatim coverage claim on global CMC requirements across 130+ countries, pre and post approval. https://clarivate.com/life-sciences-healthcare/research-development/regulatory-compliance-intelligence/chemistry-manufacturing-controls/
  9. "Cortellis Pharma Competitive Intelligence", Clarivate. Verbatim claim about 100,000+ pipeline drugs across 3,000+ diseases, primary users in portfolio strategy, BD, CI, R&D investment. https://clarivate.com/life-sciences-healthcare/portfolio-strategy/competitive-intelligence/cortellis-competitive-intelligence-analytics/
  10. "Cortellis Regulatory Intelligence AI-Powered Software", Clarivate. Global Head of Regulatory Intelligence customer quote, top 50 pharma. https://clarivate.com/life-sciences-healthcare/research-development/regulatory-compliance-intelligence/regulatory-intelligence-solutions/
  11. "Clarivate Advances Subscription Model, Explores Life Sciences Divestiture", February 2026 announcement. Morgan Stanley engaged as financial advisor on the Life Sciences & Healthcare segment sale process. https://www.tipranks.com/news/company-announcements/clarivate-advances-subscription-model-explores-life-sciences-divestiture
  12. "Top Pharma Market Intelligence Platforms in 2026", AlphaSense. Independent review of Cortellis noting "Primarily structured data with limited narrative context" and "Modules result in some data fragmentation." https://www.alpha-sense.com/resources/product-articles/pharma-market-intelligence-platforms/
  13. "Cortellis Life Sciences Intelligence Solutions", Clarivate. Module list and taglines (Competitive, Deals, Clinical Trials, Drug Discovery, Regulatory, CMC, Product, MetaBase/MetaCore, OFF-X). https://clarivate.com/life-sciences-healthcare/cortellis/
  14. "Generics Intelligence", Clarivate (Cortellis Generics, formerly Newport). Tagline and named data domains: market performance, API, patents, regulatory, inspection records, sales, volume, pricing. https://clarivate.com/life-sciences-healthcare/manufacturing-supply-chain-intelligence/

See it on your portfolio.

Book a 30-minute call. Bring three sourcing questions. We'll run them on the live data with you. No top-up needed, and you keep whatever we find.

Book a call